Watch this webinar on how PBMC-humanized models can accelerate the development of next-generation immunotherapies. Best practices and real world applications are shared that can help you generate predictive, high-value data and reduce the risks of clinical translation.
You'll learn how to optimize donor selection and screening techniques to enhance model performance and reduce graft vs. tumor (GvT) effects. Additionally, you'll discover the power of CDX models in PBMC-humanized mice as a platform for the drug discovery workflow.